A 52-year-old postmenopausal woman is placed on a drug that decreases osteoclast activation but may intensify hot flashes. Which drug was most likely given to this patient?
(A) alendronate
(B) strontium ranelate
(C) calcitonin
(D) raloxifene
(E) teriparatide